EDUCATIONAL OBJECTIVES
After attending this activity, the participant will demonstrate the ability to:
  • Apply new information on the pathogenesis of HIV and liver disease due to viral hepatitis and metabolic disfunction-associated steatotic liver disease (MASLD) in management strategies.
  • Identify antiretroviral and HBV/HCV/HDV antiviral therapies based upon the most recent USPHS, IAS-USA, AASLD, IDSA and EASL Guidelines.
  • Evaluate patients with antiretroviral and/or DAA therapy failure based upon the most recent data presented at the previous EASL, CROI, AASLD, HIV Glasgow, IAC, ICAAC, IDWeek, and EACS conferences.
  • Manage antiviral (HIV, HBV, HCV, HDV and MASLD) drug interactions, side effects, and complications of treatment incorporating the latest pharmacogenomics/kinetics/dynamics data.
  • Evaluate and manage patients for pre-exposure prophylaxis therapy to prevent HIV infection.
  • Identify management strategies of sexually transmitted infections in patients with HIV or liver disease due to viral hepatitis and MASLD.
  • Identify new prevention (including vaccinations) and management strategies for emerging pathogens such as COVID and Mpox.
AGENDA

 

 Saturday, March 22, 2025

 

 07:00 AM – 08:00 AM Breakfast  

 

 08:00 AM – 08:10 AM Introduction and Conference Goals Michael S. Saag, MD

 

 08:10 AM – 08:40 AM Antiretroviral Therapy: Starts, Switches and Rescues – Where Are We Now? Joseph J. Eron, MD

 

 08:40 AM – 09:10 AM Post-Conference Update from CROI 2025: “What Did I Miss?” Rajesh Gandhi, MD

 

 09:10 AM – 09:30 AM Panel Discussion / Questions and Answers  

 

 09:30 AM – 10:00 AM The End of Oral? The Science and Future of Long-Acting Antivirals Charles W. Flexner, MD

 

 10:00 AM – 10:30 AM When to Jab and with What: Vaccinations for People with HIV David Spach, MD

 

 10:30 AM – 10:50 AM Panel Discussion / Questions and Answers  

 

 10:50 AM – 11:05 AM Break  

 

 11:05 AM – 11:35 AM Sexually Transmitted Infections: The Old & New Meredith Clement, MD

 

 11:35 AM – 12:05 PM Pre-exposure Prophylaxis for HIV Infection: PrEP-aring for the Next Decade Raphael Landovitz, MD, MSc

 

 12:05 PM – 12:25 PM Panel Discussion / Questions and Answers  

 

 12:25 PM – 12:45 PM Break  

 

 12:45 PM – 01:45 PM Working Lunch - Case Presentations   Michael S. Saag, MD and faculty panel

 

 01:45 PM – 02:15 PM Faculty Roundtable Session 1*  

 

 02:15 PM – 02:45 PM Faculty Roundtable Session 2* (In-person attendees will have the opportunity to attend two of the three sessions)
PrEP, Prevention and STI’s Meredith Clement, MD
Raphael Landovitz, MD, MSc
Antiretroviral Therapy: Challenging Cases Joseph J. Eron, MD
David Spach, MD
Emerging Advances in HIV Treatment Charles W. Flexner, MD

 

Sunday, March 23, 2025

 

 07:00 AM – 08:00 AM Breakfast  

 

 08:00 AM – 08:10 AM Introduction and Conference Goals Mark S. Sulkowski, MD

 

 08:10 AM – 08:40 AM Management Considerations for Hepatitis C Infection, including persons with HIV Susanna Naggie, MD, MHS

 

 08:40 AM – 09:10 AM Management Considerations for Hepatitis B Infection, including in persons with HIV Debika Bhattacharya, MD, MSc

 

 09:10 AM – 09:30 AM Panel Discussion / Questions and Answers  

 

 09:30 AM – 10:00 AM The Other Hepatitis Virus: HAV, HDV and HEV Ken Sherman MD

 

 10:00 AM – 10:30 AM Obesity and HIV Suman Srinivasa, MD, MS

 

 10:30 AM – 10:45 AM Panel Discussion / Questions and Answers  

 

 10:45 AM – 11:05 AM Break  

 

 11:05 AM – 11:35 AM Epidemiology, Evaluation, and Treatment of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) in Persons with HIV Richard K. Sterling, MD

 

 11:35 AM – 12:05 PM How to Manage Patients with Substance and Alcohol Use Disorders? Glenn J. Treisman, MD, PhD

 

 12:05 PM – 12:25 PM Panel Discussion / Questions and Answers  

 

 12:25 PM – 12:45 PM Break  

 

 12:45 PM – 01:45 PM Working Lunch - Case Presentations Mark S. Sulkowski, MD and faculty panel

 

 01:45 PM – 02:15 PM Faculty Roundtable Session 1*  

 

 02:15 PM – 02:45 PM Faculty Roundtable Session 2* (In-person attendees will have the opportunity to attend two of the three sessions)
Hepatitis C: Challenging Cases Susanna Naggie, MD, MHS
Glenn J. Treisman, MD, PhD
Hepatitis B and D: More Questions and Answers Debika Bhattacharya MD, MSc
Ken Sherman, MD
Metabolic Dysfunction-Associated Steatotic Liver Disease Richard K. Sterling, MD
Suman Srinivasa, MD, MS

 

* Faculty Roundtable sessions are only available for in-person conference participants. These sessions will not be available for virtual participants.
The schedule of events and faculty are subject to change.


Rush Logo

This activity is provided in collaboration with Rush University Medical Center and Practice Point Communications.

Practice Point Communications and Rush University Medical Center do not share your name or contact information with any other party.